-
Exagamglogene autotemcel, sold
under the
brand name
Casgevy, is a gene
therapy used for the
treatment of
sickle cell
disease and transfusion-dependent...
-
CRISPR gene editing,
Casgevy, was
approved for use in the
United Kingdom to cure sickle-cell
disease and beta thal****emia.
Casgevy was
approved for use...
-
Patients with
Duchenne Muscular Dystrophy". FDA.
Retrieved 12 July 2023. "
Casgevy". U.S. Food and Drug
Administration (FDA). 8
December 2023.
Retrieved 8...
-
printing of hair
follicles on lab-grown skin is reported. 16
November Casgevy, a world-first gene
therapy that aims to cure sickle-cell
disease and...
-
Therapeutics Announce Authorization of the
First CRISPR/Cas9 Gene-Edited Therapy,
Casgevy (exagamglogene autotemcel), by the
United Kingdom MHRA for the Treatment...
-
person is
confirmed dead
following a
house fire in Hounslow, West London.
Casgevy, a world-first gene
therapy that aims to cure sickle-cell
disease and...
-
carvedilol (INN)
carvotroline (INN)
Carvykti carzelesin (INN)
carzenide (INN)
Casgevy casimersen casirivimab and
imdevimab Casodex casokefamide (INN) casopitant...
- (Hemgenix): AAV-based
treatment for
hemophilia B
Exagamglogene autotemcel (
Casgevy):
treatment for
sickle cell disease. Gendicine:
treatment for head and...
-
Therapeutics Announce Authorization of the
First CRISPR/Cas9 Gene-Edited Therapy,
Casgevy (exagamglogene autotemcel), by the
United Kingdom MHRA for the Treatment...
